Delivery Order SPE2DB20D1100-SPE2DB25FA0S3
- Not listed
- This federal contract award, valued at $27,252.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 250 mg tablets, a prescription medication used to treat prostate cancer. The contract is a Firm Fixed Price Delivery Order that runs through January 8, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Abiraterone Acetate 500 mg tablets, a medication used to treat prostate cancer. The contract has a ceiling value of $7,526.45 and is a Firm Fixed Price Delivery Order that runs through February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,016.18, is a delivery order for the supply of Abiraterone Acetate 500 mg tablets. It is a firm fixed-price contract with a performance period ending on May 14, 2025. The contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp is the prime...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,054.96 Firm Fixed Price Delivery Order contract is for the supply of 120 count bottles of Abiraterone Acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $7,100.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of abiraterone acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,835.88 and a period of performance through February 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Abiraterone Acetate 250 mg tablets, a medication used to treat prostate cancer. The contract has a firm fixed price, a ceiling value of $37,396.67, and a period of performance extending to June 27, 2025. This award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 500 mg tablets, a medication used to treat prostate cancer. The contract has a firm fixed price and a ceiling value of $21,588.55, with a period of performance through April 18, 2025. The contract is not set aside for any specific business type....
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.20, is for the delivery of abiraterone acetate 250 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Abiraterone Acetate 500 mg tablets. The $13,720.67 firm fixed-price contract has a completion date of February 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FA0S3Delivery Order
This federal contract award, valued at $73,068.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of abiraterone acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract is a Firm Fixed Price Delivery Order that runs through January 15, 2025. It is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $73.1k | 1/14/25 |